SG11201707356QA - Benzimidazole derivatives as bromodomain inhibitors - Google Patents
Benzimidazole derivatives as bromodomain inhibitorsInfo
- Publication number
- SG11201707356QA SG11201707356QA SG11201707356QA SG11201707356QA SG11201707356QA SG 11201707356Q A SG11201707356Q A SG 11201707356QA SG 11201707356Q A SG11201707356Q A SG 11201707356QA SG 11201707356Q A SG11201707356Q A SG 11201707356QA SG 11201707356Q A SG11201707356Q A SG 11201707356QA
- Authority
- SG
- Singapore
- Prior art keywords
- benzimidazole derivatives
- bromodomain inhibitors
- bromodomain
- inhibitors
- benzimidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1504689.9A GB201504689D0 (en) | 2015-03-19 | 2015-03-19 | Chemical compounds |
PCT/EP2016/055792 WO2016146738A1 (en) | 2015-03-19 | 2016-03-17 | Benzimidazole derivatives as bromodomain inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201707356QA true SG11201707356QA (en) | 2017-10-30 |
Family
ID=53052091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707356QA SG11201707356QA (en) | 2015-03-19 | 2016-03-17 | Benzimidazole derivatives as bromodomain inhibitors |
Country Status (35)
Country | Link |
---|---|
US (2) | US10442786B2 (en) |
EP (2) | EP3549939A1 (en) |
JP (1) | JP6419990B2 (en) |
KR (1) | KR102072850B1 (en) |
CN (1) | CN107635989B (en) |
AR (1) | AR103934A1 (en) |
AU (1) | AU2016232217B2 (en) |
BR (1) | BR112017019779B1 (en) |
CA (1) | CA2979504C (en) |
CL (1) | CL2017002332A1 (en) |
CO (1) | CO2017009992A2 (en) |
CR (1) | CR20170430A (en) |
CY (1) | CY1121855T1 (en) |
DK (1) | DK3271349T3 (en) |
DO (1) | DOP2017000213A (en) |
EA (1) | EA033594B1 (en) |
ES (1) | ES2735417T3 (en) |
GB (1) | GB201504689D0 (en) |
HR (1) | HRP20191186T1 (en) |
HU (1) | HUE044414T2 (en) |
IL (1) | IL254318B (en) |
LT (1) | LT3271349T (en) |
MA (2) | MA46981A (en) |
ME (1) | ME03485B (en) |
MX (1) | MX2017012023A (en) |
PE (1) | PE20180032A1 (en) |
PH (1) | PH12017501620A1 (en) |
PL (1) | PL3271349T3 (en) |
PT (1) | PT3271349T (en) |
RS (1) | RS59056B1 (en) |
SG (1) | SG11201707356QA (en) |
SI (1) | SI3271349T1 (en) |
TW (1) | TW201706257A (en) |
UY (1) | UY36589A (en) |
WO (1) | WO2016146738A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201504689D0 (en) * | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
WO2017024406A1 (en) | 2015-08-11 | 2017-02-16 | Neomed Institute | N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals |
CN108290856A (en) | 2015-08-11 | 2018-07-17 | 尼奥迈德研究所 | The substituted dihydro-quinolone of aryl-, their preparation and their purposes as drug |
EP3334719B1 (en) | 2015-08-12 | 2021-09-15 | Neomed Institute | Substituted benzimidazoles, their preparation and their use as pharmaceuticals |
WO2017066876A1 (en) | 2015-10-21 | 2017-04-27 | Neomed Institute | Substituted imidazopyridines, their preparation and their use as pharmaceuticals |
US10519151B2 (en) | 2016-01-28 | 2019-12-31 | Neomed Institute | Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals |
GB201614940D0 (en) * | 2016-09-02 | 2016-10-19 | Glaxosmithkline Intellectual Property (No 2) Ltd | Chemical compounds |
GB201614934D0 (en) * | 2016-09-02 | 2016-10-19 | Glaxosmithkline Intellectual Property (No 2) Ltd | Chemical compounds |
GB201614939D0 (en) * | 2016-09-02 | 2016-10-19 | Glaxosmithkline Ip Dev Ltd | Crystalline hydrate |
JP2020516672A (en) * | 2017-04-18 | 2020-06-11 | セルジーン クオンティセル リサーチ,インク. | Therapeutic compound |
CN109280046B (en) * | 2017-07-21 | 2021-02-02 | 浙江海正药业股份有限公司 | Benzimidazole derivative, preparation method thereof and application thereof in medicine |
JP2021512960A (en) * | 2018-02-06 | 2021-05-20 | シャンハイ ハイファ ファーマシューティカル カンパニー,リミティッド | Compounds with BET inhibitory activity and methods and uses thereof |
CN109369432B (en) * | 2018-11-02 | 2021-06-25 | 永农生物科学有限公司 | Preparation method of (S) -4-chloro-2-aminobutyrate |
JP2022053557A (en) * | 2019-02-08 | 2022-04-06 | マルホ株式会社 | Pyridone derivative |
EP3937936A4 (en) * | 2019-03-15 | 2022-12-28 | Forma Therapeutics, Inc. | Inhibiting cyclic amp-responsive element-binding protein (creb) |
CN114786675A (en) * | 2019-04-24 | 2022-07-22 | 康威基内有限公司 | Small molecule bromodomain inhibitors and uses thereof |
WO2020223370A1 (en) * | 2019-04-29 | 2020-11-05 | The Board Of Regents Of The University Of Texas System | Compositions and methods for treating schistosoma infections |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9004781D0 (en) | 1990-03-02 | 1990-04-25 | Glaxo Group Ltd | Device |
GB0201677D0 (en) | 2002-01-25 | 2002-03-13 | Glaxo Group Ltd | Medicament dispenser |
GB0515584D0 (en) | 2005-07-28 | 2005-09-07 | Glaxo Group Ltd | Medicament dispenser |
AR058289A1 (en) | 2005-12-12 | 2008-01-30 | Glaxo Group Ltd | COLLECTOR TO BE USED IN MEDICINAL DISPENSER |
PE20080130A1 (en) | 2006-03-31 | 2008-02-25 | Janssen Pharmaceutica Nv | BENZOIMIDAZOLE-2-IL PYRIMIDINES AND PIRAZINES AS MODULATORS OF THE HISTAMINE H4 RECEPTOR |
JP2013508461A (en) * | 2009-10-27 | 2013-03-07 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | Benzimidazoles as fatty acid synthase inhibitors |
GB0919423D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
GB0919434D0 (en) | 2009-11-05 | 2009-12-23 | Glaxosmithkline Llc | Novel compounds |
MA34591B1 (en) | 2010-10-06 | 2013-10-02 | Glaxosmithkline Llc | BENZIMIDAZOLE DERIVATIVES AS PI3 KINASE INHIBITORS |
GB201114103D0 (en) * | 2011-08-17 | 2011-09-28 | Glaxosmithkline Llc | Novel compounds |
WO2013097052A1 (en) * | 2011-12-30 | 2013-07-04 | Abbott Laboratories | Bromodomain inhibitors |
CA2895905A1 (en) * | 2012-12-21 | 2014-06-26 | Zenith Epigenetics Corp. | Novel heterocyclic compounds as bromodomain inhibitors |
DK2970265T3 (en) | 2013-03-15 | 2018-10-01 | Plexxikon Inc | HETEROCYCLIC COMPOUNDS AND APPLICATIONS THEREOF |
TWI530499B (en) | 2013-03-28 | 2016-04-21 | 吉李德科學股份有限公司 | Benzimidazolone derivatives as bromodomain inhibitors |
TWI527811B (en) * | 2013-05-09 | 2016-04-01 | 吉李德科學股份有限公司 | Benzimidazole derivatives as bromodomain inhibitors |
US9636328B2 (en) * | 2013-06-21 | 2017-05-02 | Zenith Epigenetics Ltd. | Substituted bicyclic compounds as bromodomain inhibitors |
US20150051208A1 (en) * | 2013-08-14 | 2015-02-19 | Boehringer Ingelheim International Gmbh | Pyridinones |
US9428515B2 (en) * | 2014-05-09 | 2016-08-30 | Boehringer Ingelheim International Gmbh | Benzimidazole derivatives |
GB201504694D0 (en) * | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Covalent conjugates |
GB201504689D0 (en) * | 2015-03-19 | 2015-05-06 | Glaxosmithkline Ip Dev Ltd | Chemical compounds |
GB201614939D0 (en) * | 2016-09-02 | 2016-10-19 | Glaxosmithkline Ip Dev Ltd | Crystalline hydrate |
-
2015
- 2015-03-19 GB GBGB1504689.9A patent/GB201504689D0/en not_active Ceased
-
2016
- 2016-03-15 AR ARP160100683A patent/AR103934A1/en unknown
- 2016-03-17 US US15/559,556 patent/US10442786B2/en active Active
- 2016-03-17 CA CA2979504A patent/CA2979504C/en active Active
- 2016-03-17 JP JP2017548404A patent/JP6419990B2/en active Active
- 2016-03-17 CR CR20170430A patent/CR20170430A/en unknown
- 2016-03-17 MA MA046981A patent/MA46981A/en unknown
- 2016-03-17 EA EA201791973A patent/EA033594B1/en not_active IP Right Cessation
- 2016-03-17 MA MA041778A patent/MA41778A/en unknown
- 2016-03-17 ME MEP-2019-171A patent/ME03485B/en unknown
- 2016-03-17 PL PL16710214T patent/PL3271349T3/en unknown
- 2016-03-17 PE PE2017001543A patent/PE20180032A1/en unknown
- 2016-03-17 UY UY0001036589A patent/UY36589A/en not_active Application Discontinuation
- 2016-03-17 TW TW105108340A patent/TW201706257A/en unknown
- 2016-03-17 BR BR112017019779-0A patent/BR112017019779B1/en active IP Right Grant
- 2016-03-17 EP EP19174047.1A patent/EP3549939A1/en not_active Withdrawn
- 2016-03-17 ES ES16710214T patent/ES2735417T3/en active Active
- 2016-03-17 HU HUE16710214 patent/HUE044414T2/en unknown
- 2016-03-17 DK DK16710214.4T patent/DK3271349T3/en active
- 2016-03-17 KR KR1020177030073A patent/KR102072850B1/en active IP Right Grant
- 2016-03-17 CN CN201680027314.8A patent/CN107635989B/en active Active
- 2016-03-17 MX MX2017012023A patent/MX2017012023A/en unknown
- 2016-03-17 WO PCT/EP2016/055792 patent/WO2016146738A1/en active Application Filing
- 2016-03-17 PT PT16710214T patent/PT3271349T/en unknown
- 2016-03-17 AU AU2016232217A patent/AU2016232217B2/en not_active Ceased
- 2016-03-17 LT LTEP16710214.4T patent/LT3271349T/en unknown
- 2016-03-17 RS RS20190986A patent/RS59056B1/en unknown
- 2016-03-17 SI SI201630321T patent/SI3271349T1/en unknown
- 2016-03-17 EP EP16710214.4A patent/EP3271349B1/en active Active
- 2016-03-17 SG SG11201707356QA patent/SG11201707356QA/en unknown
-
2017
- 2017-09-04 IL IL254318A patent/IL254318B/en active IP Right Grant
- 2017-09-07 PH PH12017501620A patent/PH12017501620A1/en unknown
- 2017-09-14 CL CL2017002332A patent/CL2017002332A1/en unknown
- 2017-09-19 DO DO2017000213A patent/DOP2017000213A/en unknown
- 2017-09-29 CO CONC2017/0009992A patent/CO2017009992A2/en unknown
-
2019
- 2019-07-01 HR HRP20191186TT patent/HRP20191186T1/en unknown
- 2019-07-26 CY CY20191100796T patent/CY1121855T1/en unknown
- 2019-08-22 US US16/547,909 patent/US11053212B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL254318B (en) | Benzimidazole derivatives as bromodomain inhibitors | |
HRP20181650T1 (en) | Bicyclic heterocyclic derivatives as bromodomain inhibitors | |
HK1243326A1 (en) | Bromodomain inhibitors | |
HK1245248B (en) | Substituted heterocycles as bromodomain inhibitors | |
HK1222646A1 (en) | Benzimidazole derivatives as bromodomain inhibitors | |
HK1246273B (en) | Substituted pyridines as bromodomain inhibitors | |
HK1243415A1 (en) | Bromodomain inhibitors | |
HRP20182064T1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
HK1232227A1 (en) | Quinolizinone derivatives as pi3k inhibitors pi3k | |
HK1252767A1 (en) | Pyrazol-pyridine derivatives as eaat3 inhibitors | |
TH1501005855A (en) | Benzimidazolone Derivatives as Bromodomain Inhibitors | |
TH1501006739A (en) | Benzimidazole derivatives that are bromodomain inhibitors |